FR2723682A1 - Absorbable nutritional supplement for children and adolescents, to ensure daily micronutrient intake - Google Patents
Absorbable nutritional supplement for children and adolescents, to ensure daily micronutrient intake Download PDFInfo
- Publication number
- FR2723682A1 FR2723682A1 FR9410269A FR9410269A FR2723682A1 FR 2723682 A1 FR2723682 A1 FR 2723682A1 FR 9410269 A FR9410269 A FR 9410269A FR 9410269 A FR9410269 A FR 9410269A FR 2723682 A1 FR2723682 A1 FR 2723682A1
- Authority
- FR
- France
- Prior art keywords
- vitamin
- pref
- nutritional supplement
- natural
- excipient
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 235000015872 dietary supplement Nutrition 0.000 title claims abstract description 15
- 235000020972 micronutrient intake Nutrition 0.000 title abstract 2
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims abstract description 24
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims abstract description 16
- 229930003427 Vitamin E Natural products 0.000 claims abstract description 13
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 claims abstract description 13
- 235000013734 beta-carotene Nutrition 0.000 claims abstract description 13
- 239000011648 beta-carotene Substances 0.000 claims abstract description 13
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 claims abstract description 13
- 229960002747 betacarotene Drugs 0.000 claims abstract description 13
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims abstract description 13
- 235000019165 vitamin E Nutrition 0.000 claims abstract description 13
- 239000011709 vitamin E Substances 0.000 claims abstract description 13
- 229940046009 vitamin E Drugs 0.000 claims abstract description 13
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 claims abstract description 11
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims abstract description 10
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims abstract description 9
- 229930003268 Vitamin C Natural products 0.000 claims abstract description 9
- 239000000546 pharmaceutical excipient Substances 0.000 claims abstract description 9
- 235000019154 vitamin C Nutrition 0.000 claims abstract description 9
- 239000011718 vitamin C Substances 0.000 claims abstract description 9
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 claims abstract description 8
- 239000011746 zinc citrate Substances 0.000 claims abstract description 8
- 229940068475 zinc citrate Drugs 0.000 claims abstract description 8
- 235000006076 zinc citrate Nutrition 0.000 claims abstract description 8
- 235000010374 vitamin B1 Nutrition 0.000 claims abstract description 7
- 239000011691 vitamin B1 Substances 0.000 claims abstract description 7
- WGIWBXUNRXCYRA-UHFFFAOYSA-H trizinc;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Zn+2].[Zn+2].[Zn+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O WGIWBXUNRXCYRA-UHFFFAOYSA-H 0.000 claims abstract description 6
- 229940088594 vitamin Drugs 0.000 claims abstract description 6
- 229930003231 vitamin Natural products 0.000 claims abstract description 6
- 235000013343 vitamin Nutrition 0.000 claims abstract description 6
- 239000011782 vitamin Substances 0.000 claims abstract description 6
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims abstract description 5
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims abstract description 5
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 claims abstract description 5
- 229910000019 calcium carbonate Inorganic materials 0.000 claims abstract description 5
- 239000008119 colloidal silica Substances 0.000 claims abstract description 5
- 239000008121 dextrose Substances 0.000 claims abstract description 5
- 235000019359 magnesium stearate Nutrition 0.000 claims abstract description 5
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims abstract description 5
- 239000008108 microcrystalline cellulose Substances 0.000 claims abstract description 5
- 229940016286 microcrystalline cellulose Drugs 0.000 claims abstract description 5
- GHOKWGTUZJEAQD-UHFFFAOYSA-N Chick antidermatitis factor Natural products OCC(C)(C)C(O)C(=O)NCCC(O)=O GHOKWGTUZJEAQD-UHFFFAOYSA-N 0.000 claims abstract description 4
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 claims abstract description 4
- DFPAKSUCGFBDDF-UHFFFAOYSA-N Nicotinamide Chemical compound NC(=O)C1=CC=CN=C1 DFPAKSUCGFBDDF-UHFFFAOYSA-N 0.000 claims abstract description 4
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims abstract description 4
- 229930003451 Vitamin B1 Natural products 0.000 claims abstract description 4
- 229930003779 Vitamin B12 Natural products 0.000 claims abstract description 4
- 229930003471 Vitamin B2 Natural products 0.000 claims abstract description 4
- 229930003571 Vitamin B5 Natural products 0.000 claims abstract description 4
- 229930003761 Vitamin B9 Natural products 0.000 claims abstract description 4
- UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 claims abstract description 4
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 claims abstract description 4
- 229960002079 calcium pantothenate Drugs 0.000 claims abstract description 4
- AGVAZMGAQJOSFJ-WZHZPDAFSA-M cobalt(2+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+2].N#[C-].[N-]([C@@H]1[C@H](CC(N)=O)[C@@]2(C)CCC(=O)NC[C@@H](C)OP(O)(=O)O[C@H]3[C@H]([C@H](O[C@@H]3CO)N3C4=CC(C)=C(C)C=C4N=C3)O)\C2=C(C)/C([C@H](C\2(C)C)CCC(N)=O)=N/C/2=C\C([C@H]([C@@]/2(CC(N)=O)C)CCC(N)=O)=N\C\2=C(C)/C2=N[C@]1(C)[C@@](C)(CC(N)=O)[C@@H]2CCC(N)=O AGVAZMGAQJOSFJ-WZHZPDAFSA-M 0.000 claims abstract description 4
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims abstract description 4
- 229910052500 inorganic mineral Inorganic materials 0.000 claims abstract description 4
- 239000011707 mineral Substances 0.000 claims abstract description 4
- 235000010755 mineral Nutrition 0.000 claims abstract description 4
- 229960002477 riboflavin Drugs 0.000 claims abstract description 4
- 150000003839 salts Chemical class 0.000 claims abstract description 4
- 229960003495 thiamine Drugs 0.000 claims abstract description 4
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 claims abstract description 4
- 235000019163 vitamin B12 Nutrition 0.000 claims abstract description 4
- 239000011715 vitamin B12 Substances 0.000 claims abstract description 4
- 235000019164 vitamin B2 Nutrition 0.000 claims abstract description 4
- 239000011716 vitamin B2 Substances 0.000 claims abstract description 4
- 235000019160 vitamin B3 Nutrition 0.000 claims abstract description 4
- 239000011708 vitamin B3 Substances 0.000 claims abstract description 4
- 235000009492 vitamin B5 Nutrition 0.000 claims abstract description 4
- 239000011675 vitamin B5 Substances 0.000 claims abstract description 4
- 235000021468 vitamin B8 Nutrition 0.000 claims abstract description 4
- 235000019159 vitamin B9 Nutrition 0.000 claims abstract description 4
- 239000011727 vitamin B9 Substances 0.000 claims abstract description 4
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 claims abstract 4
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 claims abstract 2
- 235000019158 vitamin B6 Nutrition 0.000 claims abstract 2
- 239000011726 vitamin B6 Substances 0.000 claims abstract 2
- 229940011671 vitamin b6 Drugs 0.000 claims abstract 2
- 239000000203 mixture Substances 0.000 claims description 8
- 239000011785 micronutrient Substances 0.000 claims description 4
- 235000013369 micronutrients Nutrition 0.000 claims description 4
- 239000013589 supplement Substances 0.000 claims description 3
- 239000004480 active ingredient Substances 0.000 claims description 2
- 229940016038 calcium carbonate 30 mg Drugs 0.000 claims description 2
- 229940033203 vitamin b6 0.5 mg Drugs 0.000 claims description 2
- 230000002354 daily effect Effects 0.000 description 5
- 230000003078 antioxidant effect Effects 0.000 description 3
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 2
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 2
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 210000000988 bone and bone Anatomy 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 230000037213 diet Effects 0.000 description 2
- 235000005911 diet Nutrition 0.000 description 2
- 230000012010 growth Effects 0.000 description 2
- 230000007124 immune defense Effects 0.000 description 2
- 238000004519 manufacturing process Methods 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 235000019155 vitamin A Nutrition 0.000 description 2
- 239000011719 vitamin A Substances 0.000 description 2
- 229940045997 vitamin a Drugs 0.000 description 2
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- 102000011782 Keratins Human genes 0.000 description 1
- 108010076876 Keratins Proteins 0.000 description 1
- 208000029549 Muscle injury Diseases 0.000 description 1
- 241000208125 Nicotiana Species 0.000 description 1
- 235000002637 Nicotiana tabacum Nutrition 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 230000002924 anti-infective effect Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000021152 breakfast Nutrition 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000001720 carbohydrates Chemical class 0.000 description 1
- 235000014633 carbohydrates Nutrition 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000007123 defense Effects 0.000 description 1
- 238000005115 demineralization Methods 0.000 description 1
- 230000002328 demineralizing effect Effects 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 230000003203 everyday effect Effects 0.000 description 1
- 239000003925 fat Substances 0.000 description 1
- 235000013305 food Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000008187 granular material Substances 0.000 description 1
- 230000036039 immunity Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 230000002458 infectious effect Effects 0.000 description 1
- 150000002632 lipids Chemical class 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 231100000516 lung damage Toxicity 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- 230000003472 neutralizing effect Effects 0.000 description 1
- 150000002823 nitrates Chemical class 0.000 description 1
- 238000005457 optimization Methods 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 239000000843 powder Substances 0.000 description 1
- 239000002243 precursor Substances 0.000 description 1
- 230000001681 protective effect Effects 0.000 description 1
- 238000001243 protein synthesis Methods 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 230000003236 psychic effect Effects 0.000 description 1
- 230000033764 rhythmic process Effects 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 230000001502 supplementing effect Effects 0.000 description 1
- 238000003786 synthesis reaction Methods 0.000 description 1
- 230000008467 tissue growth Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 230000014616 translation Effects 0.000 description 1
- 235000019156 vitamin B Nutrition 0.000 description 1
- 239000011720 vitamin B Substances 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/06—Aluminium, calcium or magnesium; Compounds thereof, e.g. clay
- A61K33/10—Carbonates; Bicarbonates
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/15—Vitamins
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/16—Inorganic salts, minerals or trace elements
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Inorganic Chemistry (AREA)
- Polymers & Plastics (AREA)
- Food Science & Technology (AREA)
- Engineering & Computer Science (AREA)
- Nutrition Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Epidemiology (AREA)
- Medicinal Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Description
COMPLEMENT NUTRITIONNEL ABSORBABLE POUR L'EOUILIBRE OUOTIDIEN DE L'ENFANT ET L'ADOLESCENT.ABSORBABLE NUTRITIONAL SUPPLEMENT FOR EARLY HEARING OF CHILDREN AND ADOLESCENTS.
L'invention vise un complément nutritionnel absorbable destiné à amener à l'organisme de l'enfant et l'adolescent les apports quotidiens nécessaires en nutriments pour préserver et maintenir au mieux sa forme. Il favorise un développement physique et intellectuel harmonieux. The invention relates to an absorbable nutritional supplement intended to bring to the body of the child and the adolescent the daily intakes necessary in nutrients to preserve and maintain its form as well as possible. It promotes harmonious physical and intellectual development.
Par "complément nutritionnel", on désigne un ensemble absorbable formant une supplémentation en micronutriments qui, complétant l'alimentation quotidienne, permet de renforcer l'organisme dans son ensemble. By "nutritional supplement" is meant an absorbable whole forming a micronutrient supplementation which, supplementing the daily diet, makes it possible to strengthen the organism as a whole.
L'invention permet de couvrir les besoins quotidiens de l'enfant et de l'adolescent en micronutriments et en vitamines, pour compenser les insuffisances dues notamment à une alimentation déséquilibrée et au rythme de la vie. Comme on le sait, ces insuffisances peuvent à la longue entrainer des désordres plus ou moins graves. The invention makes it possible to cover the daily needs of the child and the adolescent in micronutrients and vitamins, to compensate for the insufficiencies due in particular to an unbalanced diet and to the rhythm of life. As we know, these shortcomings can in the long run lead to more or less serious disorders.
L'invention pallie ces inconvénients. Elle consiste en un complément nutritionnel absorbable per-os à base de sels minéraux et de vitamines, pour assurer l'apport quotidien en micronutriments, qui se caractérise en ce qu'il comprend
- du carbonate de calcium;
- du citrate de zinc;
- du béta-carotène;
- un mélange de vitamines B1, B2, B5, B6, B8, B9, B12 et PP;
- de la vitamine C;
- de la vitamine E;
- et un excipient. The invention overcomes these drawbacks. It consists of an absorbable per-bone nutritional supplement based on mineral salts and vitamins, to ensure the daily intake of micronutrients, which is characterized in that it comprises
- calcium carbonate;
- zinc citrate;
- beta-carotene;
- a mixture of vitamins B1, B2, B5, B6, B8, B9, B12 and PP;
- vitamin C;
- vitamin E;
- and an excipient.
En d'autres termes, l'invention concerne une composition spécifique de sels minéraux particuliers et de vitamines particulières, qui permet d'assurer les apports quotidiens complémentaires souhaités chez l'enfant et l'adolescent. In other words, the invention relates to a specific composition of particular mineral salts and of particular vitamins, which makes it possible to ensure the daily supplements desired in children and adolescents.
Le calcium favorise l'optimisation du capital osseux atteint à la fin de la croissance chez l'adolescent, et partant réduit le risque de déminéralisation future chez la jeune femme. Calcium promotes the optimization of bone capital reached at the end of growth in adolescents, and therefore reduces the risk of future demineralization in young women.
Le zinc
- est indispensable au bon fonctionnement des cellules et à la
croissance des tissus;
- est essentiel aux systèmes de défenses anti-infectieuses et joue
un rôle important dans l'immunité.Zinc
- is essential for the proper functioning of the cells and the
tissue growth;
- is essential to anti-infectious defense systems and plays
an important role in immunity.
- est nécessaire à la synthèse des protéines, notamment la
kératine qui forme les cheveux et les ongles.- is necessary for protein synthesis, especially
keratin which forms hair and nails.
Le citrate de zinc possède un excellent rapport absorption/efficacité. Zinc citrate has an excellent absorption / efficiency ratio.
En pratique, le bétacarotène utilisé est le bétacarotène naturel. Ce composé est un précurseur de la vitamine A. Il permet à l'organisme de synthétiser de la vitamine A en fonction de ses besoins. C'est également un anti-oxydant aux propriétés particulières, capable de neutraliser les radicaux libres résultant en particulier de l'exposition au soleil. In practice, the betacarotene used is natural betacarotene. This compound is a precursor of vitamin A. It allows the body to synthesize vitamin A according to its needs. It is also an antioxidant with special properties, capable of neutralizing free radicals resulting in particular from exposure to the sun.
Les vitamines B et PP sont essentielles à
- la bonne assimilation des nutriments (protéines, lipides,
glucides) apportés par l'alimentation,
- la production de l'énergie,
- la synthèse des neurotransmetteurs dont dépendent les capacités
de concentration et de mémorisation.Vitamins B and PP are essential to
- the proper assimilation of nutrients (proteins, lipids,
carbohydrates) provided by food,
- energy production,
- the synthesis of neurotransmitters on which the capacities depend
of concentration and memorization.
La vitamine E utilisée est de préférence la vitamine E naturelle. Elle diminue le risque de dommages pulmonaires provoqués par la pollution, et de dommages musculaires crées par l'effort. Elle joue un rôle d'antioxydant protecteur des graisses. The vitamin E used is preferably natural vitamin E. It reduces the risk of lung damage caused by pollution, and muscle damage created by exertion. It acts as a protective antioxidant for fats.
La vitamine C joue un rôle essentiel dans
- l'énergie physique et psychique,
- les défenses immunitaires,
- la protection contre les toxiques (tabac, vapeurs d'essence,
nitrates, pesticides ...),
- la solidité de la trame osseuse,
- la santé des gencives,
- la réduction de la durée et de l'intensité des épisodes
infectieux.Vitamin C plays an essential role in
- physical and psychic energy,
- immune defenses,
- protection against toxic substances (tobacco, petrol vapors,
nitrates, pesticides ...),
- the strength of the bone structure,
- gum health,
- reduction in the duration and intensity of episodes
infectious.
La combinaison de la vitamine C, de la vitamine E et du bétacarotène provoque une synergie qui exacerbe les actions antioxydantes de chacun de ces trois composants. The combination of vitamin C, vitamin E and betacarotene causes a synergy that exacerbates the antioxidant actions of each of these three components.
Les excipients sont avantageusement constitués par un mélange de dextrose, de cellulose micro-cristalline, de silice colloïdale utilisée pour ses propriétés anti-agglomérantes lors de la fabrication des comprimés, et enfin de stéarate de magnésium connu comme agent lubrifiant de compression. The excipients are advantageously constituted by a mixture of dextrose, microcrystalline cellulose, colloidal silica used for its anti-caking properties during the manufacture of the tablets, and finally magnesium stearate known as a compressive lubricating agent.
Dans une forme d'exécution pratique, le complément nutritionnel conforme à l'invention sous forme de comprimés de trois cents (300) milligrammes contient en poids et en pourcent en poids de principes actifs:
- 110 mg, soit 65,86682 % de carbonate de calcium
- 30 mg, soit 17,95% de vitamine C
- 16 mg, soit 9,55% de citrate de zinc
- 5 mg, soit 2,99% de vitamine PP
- 2 mg, soit 1,2% de vitamine E naturelle
-0,5 mg, soit 0,30% de bétacarotène naturel
-2mg,soit 1,2% de vitamine B5
-0,6 mg, soit 0,36% de vitamine B6
-0,5 mg, soit 0,30% de vitamine B2
-0,4 mg, soit 0,24% de vitamine B1
- 67 Rg, soit 0,04% de vitamine B9
- 50 Rg, soit 0,003% de vitamine B8
- 0,3 Fg, soit 0,00018% de vitamine B12
- et le complément en masse à 300 mg d'un excipient formé par un
mélange de dextrose, cellulose microcristalline, silice colloïdale et de
stéarate de magnésium.In a practical embodiment, the nutritional supplement according to the invention in the form of tablets of three hundred (300) milligrams contains by weight and in percent by weight of active ingredients:
- 110 mg, i.e. 65.86682% calcium carbonate
- 30 mg, or 17.95% of vitamin C
- 16 mg, i.e. 9.55% zinc citrate
- 5 mg, or 2.99% of vitamin PP
- 2 mg, i.e. 1.2% natural vitamin E
-0.5 mg, i.e. 0.30% natural betacarotene
-2mg, i.e. 1.2% vitamin B5
-0.6 mg, i.e. 0.36% vitamin B6
-0.5 mg, i.e. 0.30% vitamin B2
-0.4 mg, i.e. 0.24% vitamin B1
- 67 Rg, or 0.04% of vitamin B9
- 50 Rg, or 0.003% of vitamin B8
- 0.3 Fg, or 0.00018% of vitamin B12
- and the mass supplement to 300 mg of an excipient formed by a
mixture of dextrose, microcrystalline cellulose, colloidal silica and
magnesium stearate.
Pour garantir l'intégrité des différents composés, on effectue avantageusement la formulation en deux phases, respectivement une phase humide puis une phase sèche qui intègre les principes actifs fragiles, dont notamment les vitamines. To guarantee the integrity of the various compounds, the formulation is advantageously carried out in two phases, respectively a wet phase and then a dry phase which incorporates the fragile active principles, including in particular the vitamins.
Le complément nutritionnel conforme à l'invention peut être absorbé sous forme de poudre, de gélules, de granules, mais de préférence sous forme de comprimés. The nutritional supplement according to the invention can be absorbed in the form of powder, capsules, granules, but preferably in the form of tablets.
Ce complément nutritionnel, sous forme de comprimés de 300 mg, peut être avalé tous les jours, à la fin du petit déjeuner, à raison de
-un comprimé pour les enfants de 4 à 9 ans,
- deux comprimés pour les enfants et adolescents de 10 à 15 ans.This nutritional supplement, in the form of tablets of 300 mg, can be swallowed every day, at the end of breakfast, at a rate of
-a tablet for children from 4 to 9 years old,
- two tablets for children and adolescents from 10 to 15 years old.
Le complément se caractérise par la bonne compatibilité des composants entre eux et leur synergie d'action, ce qui contribue avantageusement chez l'enfant et l'adolescent:
- à favoriser une croissance équilibrée;
- à améliorer la forme physique et intellectuelle;
- et à stimuler les défenses immunitaires. The complement is characterized by the good compatibility of the components with each other and their synergy of action, which advantageously contributes to children and adolescents:
- to promote balanced growth;
- to improve physical and intellectual fitness;
- and to stimulate the immune defenses.
Claims (6)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9410269A FR2723682B1 (en) | 1994-08-19 | 1994-08-19 | ABSORBABLE NUTRITIONAL SUPPLEMENT FOR THE DAILY BALANCE OF CHILDREN AND ADOLESCENTS. |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| FR9410269A FR2723682B1 (en) | 1994-08-19 | 1994-08-19 | ABSORBABLE NUTRITIONAL SUPPLEMENT FOR THE DAILY BALANCE OF CHILDREN AND ADOLESCENTS. |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| FR2723682A1 true FR2723682A1 (en) | 1996-02-23 |
| FR2723682B1 FR2723682B1 (en) | 1996-09-27 |
Family
ID=9466478
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| FR9410269A Expired - Fee Related FR2723682B1 (en) | 1994-08-19 | 1994-08-19 | ABSORBABLE NUTRITIONAL SUPPLEMENT FOR THE DAILY BALANCE OF CHILDREN AND ADOLESCENTS. |
Country Status (1)
| Country | Link |
|---|---|
| FR (1) | FR2723682B1 (en) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1175203A1 (en) * | 1999-04-30 | 2002-01-30 | Drugtech Corporation | Folic acid supplement |
| FR2851920A1 (en) * | 2003-03-06 | 2004-09-10 | Larena Sa | Compositions containing a glucose homeostasis modulator, a cardiovascular agent, and an antioxidant for the prevention and treatment of metabolic syndrome |
Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4684529A (en) * | 1984-03-09 | 1987-08-04 | Kabushiki Kaisha Fuji Kikaku | Process for the preparation of iodizable calcium composition |
| WO1991011117A2 (en) * | 1990-02-05 | 1991-08-08 | Board Of Regents, The University Of Texas System | Dietary supplements comprising vitamins and minerals |
| WO1992021355A1 (en) * | 1991-05-28 | 1992-12-10 | The Procter & Gamble Company | Calcium, trace mineral, vitamin d and drug therapy combinations |
| FR2693876A1 (en) * | 1992-07-24 | 1994-01-28 | Vani | Micro-nutrient compsn. to combat the effects of stress - contains B vitamin(s), octacosanol, calcium, magnesium, chromium and zinc and opt. other micro-nutrients |
| EP0596717A1 (en) * | 1992-11-05 | 1994-05-11 | Chandra Consultants | Nutritional supplement for the elderly |
| FR2704393A1 (en) * | 1993-04-30 | 1994-11-04 | Boiron | Nutritional supplement which can be taken orally to optimise growth and maintain robustness of bones |
-
1994
- 1994-08-19 FR FR9410269A patent/FR2723682B1/en not_active Expired - Fee Related
Patent Citations (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4684529A (en) * | 1984-03-09 | 1987-08-04 | Kabushiki Kaisha Fuji Kikaku | Process for the preparation of iodizable calcium composition |
| WO1991011117A2 (en) * | 1990-02-05 | 1991-08-08 | Board Of Regents, The University Of Texas System | Dietary supplements comprising vitamins and minerals |
| WO1992021355A1 (en) * | 1991-05-28 | 1992-12-10 | The Procter & Gamble Company | Calcium, trace mineral, vitamin d and drug therapy combinations |
| FR2693876A1 (en) * | 1992-07-24 | 1994-01-28 | Vani | Micro-nutrient compsn. to combat the effects of stress - contains B vitamin(s), octacosanol, calcium, magnesium, chromium and zinc and opt. other micro-nutrients |
| EP0596717A1 (en) * | 1992-11-05 | 1994-05-11 | Chandra Consultants | Nutritional supplement for the elderly |
| FR2704393A1 (en) * | 1993-04-30 | 1994-11-04 | Boiron | Nutritional supplement which can be taken orally to optimise growth and maintain robustness of bones |
Cited By (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| EP1175203A1 (en) * | 1999-04-30 | 2002-01-30 | Drugtech Corporation | Folic acid supplement |
| JP2002543107A (en) * | 1999-04-30 | 2002-12-17 | ドラッグテック コーポレイション | Folic acid supplements |
| EP1175203A4 (en) * | 1999-04-30 | 2004-02-25 | Drugtech Corp | Folic acid supplement |
| EP1857102A1 (en) * | 1999-04-30 | 2007-11-21 | Drugtech Corporation | Folic acid supplement |
| FR2851920A1 (en) * | 2003-03-06 | 2004-09-10 | Larena Sa | Compositions containing a glucose homeostasis modulator, a cardiovascular agent, and an antioxidant for the prevention and treatment of metabolic syndrome |
Also Published As
| Publication number | Publication date |
|---|---|
| FR2723682B1 (en) | 1996-09-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| US9907769B2 (en) | Compositions and methods for the sustained release of betaalanine | |
| US7445807B2 (en) | Agglomerated granular protein-rich nutritional supplement | |
| FR2882896A1 (en) | Supplementary food composition, useful e.g. to treat and/or prevent sarcopenia, comprises proteins rich in branched amino acids, ginsenosides, zinc, selenium, vitamins (B complex, D, C and E), algal extract, polyphenols and carotenoids | |
| FR2704393A1 (en) | Nutritional supplement which can be taken orally to optimise growth and maintain robustness of bones | |
| TW200526193A (en) | Anti-aging composition | |
| FR2737849A1 (en) | Orally administered food supplement for adults of over forty | |
| FR2723682A1 (en) | Absorbable nutritional supplement for children and adolescents, to ensure daily micronutrient intake | |
| FR2723680A1 (en) | Absorbable nutritional supplement to ensure daily micronutrient intake | |
| CN105685628A (en) | Compound calcium chewable tablets and preparation method thereof | |
| HU228455B1 (en) | Use of food supplement as slimming composition | |
| FR2808657A1 (en) | Edible composition containing micronized nacre powder of specific particle size, as high bioavailability calcium supplement for promoting osteogenesis in humans or animals | |
| JP2008237058A (en) | Dietary supplement | |
| FR2723681A1 (en) | Orally-absorbable nutritional supplement for daily admin. to females | |
| FR2704392A1 (en) | Nutritional supplement which can be taken orally to improve and optimise individuals' levels of physical and mental activity | |
| JP7069531B2 (en) | Capsules containing pyrroloquinoline quinone or a salt thereof and branched chain amino acids | |
| FR2723683A1 (en) | Orally-absorbable nutritional supplement for pregnant females | |
| RU2671633C1 (en) | Highly effective hematogen | |
| ES2786774B2 (en) | Composition for NADH coenzyme compound, preparation and application thereof. | |
| WO2020260500A1 (en) | Combination product for helping maintain the natural defenses of the organism | |
| CN1293831C (en) | Effervescent solid beverage of amino acid chelated calcium and its prepn | |
| CA3086386A1 (en) | Dietary supplements and use thereof on menses | |
| JP2007238520A (en) | Health food and supplement for sleep-inducement | |
| RU2323599C1 (en) | Biologically active food additive and its production method | |
| FR2704391A1 (en) | Nutritional supplement which can be taken orally to facilitate adaptation to daily stress | |
| FR2813762A1 (en) | A nutritional supplement to alleviate menopausal symptoms and reduce premature aging contains soya, and anti-oxidants |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| ST | Notification of lapse |